Last updated on June 2019

Rhodiola Rosea in Adults With Attention Deficit/Hyperactivity Disorder


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Attention deficit hyperactivity disorder
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Fulfillment of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, (DSM-5) diagnostic criteria for ADHD in Adults
  • Intelligence Quotient (IQ) above 70
  • Eligibility to Rhodiola rosea

Exclusion Criteria:

  • clinical contraindication fro Rhodiola rosea -
  • any unstable chronic illness without proper treatment (hypertension, heart, kidney or liver disease)
  • any significant neurological disease (delirium, dementia, epilepsy, AIDS, head trauma, multiple sclerosis, stroke, etc)
  • unstable psychiatric comorbidities requiring immediate treatment (risk of suicide, current Substance Use Disorder, etc.)
  • pregnant, nursing or absence of reliable contraception
  • current use of nicotine (<30 days)
  • use of anticoagulants
  • current use of any psychoactive drug (<30 days)
  • prior use of stimulants
  • current or lifetime psychosis- current or lifetime bipolar disorder

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.